CervoMed Inc.CRVONASDAQ
Loading
Operating Income Growth Recovery in ProgressRecovering
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P29
Within normal range
vs 3Y Ago
-0.6x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-55.23%
2024-133.30%
2023-124.80%
202285.92%
2021-54.47%
2020-38.29%
20193.97%
2018-6.00%
201723.70%
2016-132.16%